130 related articles for article (PubMed ID: 8811349)
1. Role for CD30 in HIV expression.
Romagnani S; Annunziato F; Manetti R; Almerigogna F; Biagiotti R; Giudizi MG; Ravina A; Giannò V; Tomasévic L; Maggi E
Immunol Lett; 1996 Jun; 51(1-2):83-8. PubMed ID: 8811349
[TBL] [Abstract][Full Text] [Related]
2. Activation of HIV expression by CD30 triggering in CD4+ T cells from HIV-infected individuals.
Maggi E; Annunziato F; Manetti R; Biagiotti R; Giudizi MG; Ravina A; Almerigogna F; Boiani N; Alderson M; Romagnani S
Immunity; 1995 Aug; 3(2):251-5. PubMed ID: 7648397
[TBL] [Abstract][Full Text] [Related]
3. Critical roles of CD30/CD30L interactions in murine autoimmune diabetes.
Chakrabarty S; Nagata M; Yasuda H; Wen L; Nakayama M; Chowdhury SA; Yamada K; Jin Z; Kotani R; Moriyama H; Shimozato O; Yagita H; Yokono K
Clin Exp Immunol; 2003 Sep; 133(3):318-25. PubMed ID: 12930356
[TBL] [Abstract][Full Text] [Related]
4. Cross-linking of CD30 induces HIV expression in chronically infected T cells.
Biswas P; Smith CA; Goletti D; Hardy EC; Jackson RW; Fauci AS
Immunity; 1995 Jun; 2(6):587-96. PubMed ID: 7540942
[TBL] [Abstract][Full Text] [Related]
5. CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host disease.
Blazar BR; Levy RB; Mak TW; Panoskaltsis-Mortari A; Muta H; Jones M; Roskos M; Serody JS; Yagita H; Podack ER; Taylor PA
J Immunol; 2004 Sep; 173(5):2933-41. PubMed ID: 15322151
[TBL] [Abstract][Full Text] [Related]
6. A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection.
Tang C; Yamada H; Shibata K; Muta H; Wajjwalku W; Podack ER; Yoshikai Y
J Immunol; 2008 Nov; 181(9):6316-27. PubMed ID: 18941223
[TBL] [Abstract][Full Text] [Related]
7. CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin.
Gattei V; Degan M; Gloghini A; De Iuliis A; Improta S; Rossi FM; Aldinucci D; Perin V; Serraino D; Babare R; Zagonel V; Gruss HJ; Carbone A; Pinto A
Blood; 1997 Mar; 89(6):2048-59. PubMed ID: 9058727
[TBL] [Abstract][Full Text] [Related]
8. Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells.
Cerutti A; Schaffer A; Goodwin RG; Shah S; Zan H; Ely S; Casali P
J Immunol; 2000 Jul; 165(2):786-94. PubMed ID: 10878352
[TBL] [Abstract][Full Text] [Related]
9. Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines.
Gruss HJ; DaSilva N; Hu ZB; Uphoff CC; Goodwin RG; Drexler HG
Leukemia; 1994 Dec; 8(12):2083-94. PubMed ID: 7528856
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of CD30 ligand and interleukin 4 (IL-4) receptors by acute myeloid leukaemia blasts is associated with the expansion of IL-4-producing CD30+ normal T cells.
Rossi FM; Degan M; Mazzocco FT; Di Francia R; Aldinucci D; Poletto D; Vellenga E; Pinto A; Gattei V
Br J Haematol; 2002 Apr; 117(1):59-69. PubMed ID: 11918534
[TBL] [Abstract][Full Text] [Related]
11. Reverse signaling via CD30 ligand.
Wiley SR; Goodwin RG; Smith CA
J Immunol; 1996 Oct; 157(8):3635-9. PubMed ID: 8871664
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the CD30L binding domain on the human CD30 molecule using anti-CD30 antibodies.
Franke AC; Jung D; Ellis TM
Hybridoma; 2000 Feb; 19(1):43-8. PubMed ID: 10768840
[TBL] [Abstract][Full Text] [Related]
13. CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.
Gruss HJ; Pinto A; Gloghini A; Wehnes E; Wright B; Boiani N; Aldinucci D; Gattei V; Zagonel V; Smith CA; Kadin ME; von Schilling C; Goodwin RG; Herrmann F; Carbone A
Am J Pathol; 1996 Aug; 149(2):469-81. PubMed ID: 8701986
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD30 mRNA, CD30L mRNA and a variant form of CD30 mRNA in restimulated peripheral blood mononuclear cells (PBMC) of patients with helminthic infections resembling a Th2 disease.
Kilwinski J; Berger T; Mpalaskas J; Reuter S; Flick W; Kern P
Clin Exp Immunol; 1999 Jan; 115(1):114-9. PubMed ID: 9933429
[TBL] [Abstract][Full Text] [Related]
15. CD30 ligand in lymphoma patients with CD30+ tumors.
Younes A; Consoli U; Snell V; Clodi K; Kliche KO; Palmer JL; Gruss HJ; Armitage R; Thomas EK; Cabanillas F; Andreeff M
J Clin Oncol; 1997 Nov; 15(11):3355-62. PubMed ID: 9363866
[TBL] [Abstract][Full Text] [Related]
16. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis.
Akiba H; Miyahira Y; Atsuta M; Takeda K; Nohara C; Futagawa T; Matsuda H; Aoki T; Yagita H; Okumura K
J Exp Med; 2000 Jan; 191(2):375-80. PubMed ID: 10637281
[TBL] [Abstract][Full Text] [Related]
17. OX40 ligand and CD30 ligand are expressed on adult but not neonatal CD4+CD3- inducer cells: evidence that IL-7 signals regulate CD30 ligand but not OX40 ligand expression.
Kim MY; Anderson G; White A; Jenkinson E; Arlt W; Martensson IL; Erlandsson L; Lane PJ
J Immunol; 2005 Jun; 174(11):6686-91. PubMed ID: 15905508
[TBL] [Abstract][Full Text] [Related]
18. High CD30 ligand expression by epithelial cells and Hassal's corpuscles in the medulla of human thymus.
Romagnani P; Annunziato F; Manetti R; Mavilia C; Lasagni L; Manuelli C; Vannelli GB; Vanini V; Maggi E; Pupilli C; Romagnani S
Blood; 1998 May; 91(9):3323-32. PubMed ID: 9558389
[TBL] [Abstract][Full Text] [Related]
19. CD30L/CD30 signaling regulates the formation of the tumor immune microenvironment and inhibits intestinal tumor development of colitis-associated colon cancer in mice.
Wang X; Gao Y; Zhang X; Wang X; Wang B; Meng X; Yoshikai Y; Wang Y; Sun X
Int Immunopharmacol; 2020 Jul; 84():106531. PubMed ID: 32353687
[TBL] [Abstract][Full Text] [Related]
20. Construction and expression of a soluble form of human CD30 ligand with functional activity.
Powell IF; Li T; Jäck HM; Ellis TM
J Leukoc Biol; 1998 Jun; 63(6):752-7. PubMed ID: 9620669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
